- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Database Helps Clinicians Determine Whether COVID-19 Causes Diabetes
In this episode of Managed Care Cast, Francesco Rubino, MD, discusses the potential bidirectional relationship between coronavirus disease 2019 (COVID-19) and diabetes.
Diabetes is an established risk factor for more severe cases of coronavirus disease 2019 (COVID-19). But recently reported cases of COVID-19-related diabetes among those with no preexisting risk factors suggest the 2 conditions may have a bidirectional relationship.
Interested in these rare cases, which don’t appear to fit the typical 2 types of diabetes, Francesco Rubino, MD, a professor of metabolic and bariatric surgery at King’s College London, along with a cohort of clinicians from around the world, devised a global registry of COVID-19-related diabetes to better track and understand this condition.
The CoviDiab Registry was created to establish the extent and characteristics of new-onset, COVID-19-related diabetes, and to investigate its pathogenesis, management and outcomes. On this episode of Managed Care Cast, we speak with Rubino about these new cases, the registry’s progress, and future implications of COVID-19-related diabetes.
Listen above or through one of these podcast services:
Read more:
Diabetes Risk Factors Dominate Top Causes of Global Mortality, Heighten COVID-19 Risks
Kaiser Study: Severe Obesity Boosts Risk of COVID-19 Death, Especially for the Young
Hyperglycemia Is an Independent Risk Factor of COVID-19 Mortality
Experts Issue Guidance on Concurrent COVID-19, Diabetes Treatment
COVID-19 Risk Demonstrates Importance of Keeping Diabetes Under Control
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
September 20th 2024The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the US—Caremark, Express Scripts, and Optum Rx—of inflating insulin costs for patients, prompting renewed calls for PBM reform.
Read More
Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes
September 5th 2024This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.
Read More
